Maropitant Oral Suspension (Anhydrous)
Maropitant is an FDA-approved preparation containing Maropitant, for veterinary use. Available by prescription.
How to Give Anhydrous Oral Suspension
Oral Suspension (Anhydrous) is a liquid medication that does not contain water in its base. This might be an oil-based or other special base to help stabilize the medicine. It will look like a regular liquid medication, but often needs a good shake because the drug can settle. Here's how to give it:
- Shake well each time to mix the medication (5-10 seconds).
- Measure the dose using the syringe/dropper provided or one recommended by your vet. Insert the top of the oral syringe into the bottle adapter. Turn the bottle upside down and pull the plunger until the medicine reaches the volume required
- Hold your pet steady: a towel or helper can assist with squirmy pets.
- Administer the dose slowly into the side of the mouth. Allow small pauses if needed for swallowing.
- Raise the head slightly to help the medication go down and clean any spills with a little water or tissue.
- Praise your pet and offer a treat or water (unless advised against feeding right after).
- Clean the syringe with water immediately after use. Store the bottle as directed, out of sunlight.
- Consistency is key: Shake each time, measure accurately, and contact your vet if any issues arise.
Maropitant citrate is a neurokinin-1 (NK1) receptor antagonist utilized extensively in veterinary medicine as an antiemetic. It is a prescription medication available for use in dogs and cats, requiring a valid veterinarian-client-patient relationship before it can be dispensed. It is frequently considered in the context of recovery for patients presented with vomiting or motion sickness.
The actions described here reflect the product's FDA-approved labeling; your veterinarian determines the appropriate use for your animal.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring.
At a pharmacological level, maropitant is considered for its role in managing the vomiting center in the brain by blocking the binding of Substance P. Commonly observed effects include localized changes at the site of administration or behavioral shifts like temporary lethargy. Because it influences neurological signaling related to nausea, your veterinarian will monitor for observational signs of improved comfort. Owners should monitor for any unusual behavioral shifts or persistent digestive distress and contact their veterinarian promptly. It is typically evaluated carefully in patients with known hepatic impairment.
Yes. Maropitant is a prescription medication and requires a valid authorization from a licensed veterinarian. Mixlab verifies all legal requirements before any medication is prepared or shipped.
Yes. Mixlab specializes in compounding maropitant into customized strengths and flavored oral formats, such as flavored oral liquids or treats, to support easier administration for your pet.
Veterinarians discuss maropitant because it is considered to block the specific signals in the brain that trigger the vomiting reflex. Your veterinarian will determine if it is appropriate for your pet's comfort during vomiting or nausea.
Veterinarians frequently discuss maropitant in the context of motion sickness. Your veterinarian will provide guidance on the administration schedule and the most appropriate way to support your pet during travel.
Your veterinarian will recommend periodic check-ups to monitor the clinical response. For pets with liver challenges, they may suggest blood work to ensure the management approach remains suitable.
